Ligand Pharmaceuticals Names Director Todd C. Davis as CEO
Go back to Ligand Pharmaceuticals Names Director Todd C. Davis as CEO| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 294.05 +5.23 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.82 | 52 Week High | $139.79 | |||
| Open | $287.61 | 52 Week Low | $82.07 | |||
| Day High | $294.68 | P/E | 683.84 | |||
| Day Low | $287.20 | EPS | $0.43 | |||
| Volume | 88,655 | |||||

